MV Capital Management’s Quest Diagnostics DGX Stock Holding History

MV Capital Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.7K	Buy	74 +1	+1%	+$196	﹤0.01%	487
2026 Q1	$14.3K	Hold	73	–	–	﹤0.01%	484
2025 Q4	$12.7K	Hold	73	–	–	﹤0.01%	496
2025 Q3	$13.9K	Sell	73 -6	-8%	-$1.06K	﹤0.01%	472
2025 Q2	$14.2K	Buy	79 +6	+8%	+$1.04K	﹤0.01%	485
2025 Q1	$12.4K	Buy	73 +1	+1%	+$164	﹤0.01%	491
2024 Q4	$10.9K	Buy	72 +12	+20%	+$1.87K	﹤0.01%	507
2024 Q3	$9.31K	Buy	60 +1	+2%	+$149	﹤0.01%	544
2024 Q2	$8.08K	Buy	59 +27	+84%	+$3.7K	﹤0.01%	555
2024 Q1	$4.26K	Sell	32 -537	-94%	-$69.7K	﹤0.01%	620
2023 Q4	$78.5K	Sell	569 -14	-2%	-$1.84K	0.01%	249
2023 Q3	$71K	Sell	583 -6	-1%	-$799	0.01%	243
2023 Q2	$82.8K	Sell	589 -139	-19%	-$19.2K	0.01%	228
2023 Q1	$103K	Buy	728 +695	+2,106%	+$99.4K	0.01%	204
2022 Q4	$5.16K	Sell	33 -3	-8%	-$431	﹤0.01%	553
2022 Q3	$4K	Sell	36 -1	-3%	-$132	﹤0.01%	566
2022 Q2	$5K	Buy	37 +1	+3%	+$136	﹤0.01%	555
2022 Q1	$5K	Sell	36 -4	-10%	-$558	﹤0.01%	590
2021 Q4	$7K	Sell	40 -3	-7%	-$456	﹤0.01%	527
2021 Q3	$6K	Buy	43 +15	+54%	+$2.19K	﹤0.01%	546
2021 Q2	$4K	Buy	+28	New	+$3.67K	﹤0.01%	522
2017 Q4	–	Sell	-26	Closed	-$2K	–	366
2017 Q3	$2K	Hold	26	–	–	﹤0.01%	339
2017 Q2	$3K	Buy	+26	New	+$2.75K	﹤0.01%	310
2015 Q2	–	Sell	-801	Closed	-$62K	–	421
2015 Q1	$62K	Sell	801 -423	-35%	-$30.3K	0.03%	153
2014 Q4	$82K	Buy	+1,224	New	+$77.2K	0.04%	128

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

MV Capital Management's DGX Position: Q2 2026 in Review

MV Capital Management increased its Quest Diagnostics (DGX) stake by 1.4% in Q2 2026, buying an estimated $196 and bringing the position to 74 shares worth $15.7K. The position accounts for ﹤0.01% of the portfolio, ranked #487.

MV Capital Management first reported a position in DGX in Q4 2014 and has held it in 25 quarters since. The position peaked at $103K in Q1 2023. 1,099 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

MV Capital Management held 74 shares of Quest Diagnostics worth $15.7K as of Q2 2026.
MV Capital Management bought 1 Quest Diagnostics share in Q2 2026, an estimated $196.
Quest Diagnostics made up ﹤0.01% of MV Capital Management's portfolio in Q2 2026, its #487 holding.
MV Capital Management first reported a position in Quest Diagnostics in Q4 2014 and has held it in 25 quarters since.
MV Capital Management's Quest Diagnostics position peaked at $103K in Q1 2023.
1,099 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on MV Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.